USD 25.72
(1.94%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 | -75.53 Million USD | 54.9% |
2023 | -167.5 Million USD | 43.79% |
2022 | -298.01 Million USD | -45.76% |
2021 | -204.46 Million USD | -207.69% |
2020 | -66.45 Million USD | -316.15% |
2019 | 30.74 Million USD | 147.3% |
2018 | 12.43 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q4 | -75.53 Million USD | 15.15% |
2024 Q1 | -135.14 Million USD | 19.32% |
2024 Q2 | -111.87 Million USD | 17.22% |
2024 FY | -75.53 Million USD | 54.9% |
2024 Q3 | -89.02 Million USD | 20.43% |
2023 Q1 | -254.84 Million USD | 14.49% |
2023 FY | -167.5 Million USD | 43.79% |
2023 Q4 | -167.5 Million USD | 15.72% |
2023 Q3 | -198.73 Million USD | 12.89% |
2023 Q2 | -228.14 Million USD | 10.47% |
2022 Q4 | -298.01 Million USD | 23.28% |
2022 Q2 | -427.21 Million USD | 2.5% |
2022 FY | -298.01 Million USD | -45.76% |
2022 Q3 | -388.43 Million USD | 9.08% |
2022 Q1 | -438.19 Million USD | -114.32% |
2021 Q3 | -221.51 Million USD | -313.93% |
2021 Q1 | -63.19 Million USD | 4.91% |
2021 FY | -204.46 Million USD | -207.69% |
2021 Q4 | -204.46 Million USD | 7.7% |
2021 Q2 | -53.51 Million USD | 15.31% |
2020 Q4 | -66.45 Million USD | 1.77% |
2020 FY | -66.45 Million USD | -316.15% |
2020 Q3 | -67.65 Million USD | 11.25% |
2020 Q2 | -76.22 Million USD | -337.72% |
2020 Q1 | 32.06 Million USD | 4.3% |
2019 Q4 | 30.74 Million USD | 0.0% |
2019 FY | 30.74 Million USD | 147.3% |
2019 Q1 | 10.5 Million USD | 0.0% |
2018 FY | 12.43 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
American Well Corporation | -360.25 Million USD | 79.032% |
Doximity, Inc. | -82.23 Million USD | 8.149% |
Evolent Health, Inc. | 451.97 Million USD | 116.713% |
MultiPlan Corporation | 4.48 Billion USD | 101.684% |
Teladoc Health, Inc. | 468.6 Million USD | 116.12% |
Veeva Systems Inc. | -647.71 Million USD | 88.338% |